4,4'-(Cyclohexane-1,1-diyl)bis(N,N-di-p-tolylaniline), 98%, 1g

?-D-Glucopyranose, 2-amino-2-deoxy-, 1,3,4,6-tetraacetate, hydrochloride (1:1), 97%, 250mg

1-[(4-methylphenyl)sulfonyl]-3-azetidinone, 95.0%, 25g

7-Fluoro-2-methyl-2H-indazole, 95.0%, 5g

8-ethyl-4-(3-phenylpropanoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

(R)-2,2,2-Trifluoro-1-(3-(trifluoromethyl)phenyl)ethanamine hydrochloride, 95%, 1g

5-Cyclopropyl-1,3,4-oxadiazol-2-ol, 95.0%, 250mg

5-Amino-2-chloronicotinonitrile, 95.0%, 1g

(R)-BENZYL 2-((TERT-BUTOXYCARBONYL)AMINO)-5-(DIMETHYLAMINO)-5-OXOPENTANOATE, 95.0%, 1g

methyl 1-(benzenesulfonyl)-3-methyl-1H-indole-2-carboxylate, 97.0%, 1g

ethyl 5-amino-1-(2,3-dimethylphenyl)-1H-pyrazole-3-carboxylate, 95.0%, 2g

Nestable barrel with UN approval, 40 l, 1 Piece

1-(6-Methylpyridin-2-yl)ethan-1-amine dihydrochloride, 96%, 1g